Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder
Trial Snapshot
- Phase
- Phase 4
- Sponsor
- University of Cincinnati
- Enrollment
- 260
- Locations
- 1
- Primary Endpoint
- The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium.
Study Overview
Brief Summary
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium, an FDA-approved treatment for bipolar mania, in order to better understand who benefits from treatment and why they respond to medications. Studying this may help improve treatment and outcome in patients with bipolar disorder.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Basic Science
- Masking
- None
Eligibility Criteria
- Ages
- 15 Years to 55 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Arms & Interventions
1
Manic Patients
Intervention: Lithium (Drug)
2
Depressed Patients
Intervention: Lithium (Drug)
Outcomes
Primary Outcomes
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium.
Time Frame: 8 weeks
Secondary Outcomes
No secondary outcomes reported
Investigators
Caleb M. Adler
Associate Professor
University of Cincinnati
